Free Trial

BIOLASE Q3 2023 Earnings Report

BIOLASE logo
$0.0074 -0.01 (-50.67%)
(As of 12/19/2024 ET)

BIOLASE Earnings Headlines

Biolase Inc (BIOLQ)
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong
Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.
Biolase Inc. Faces Bankruptcy Amid Strategic Asset Sale
Sonendo, Inc. Reports Third Quarter 2024 Financial Results
See More BIOLASE Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BIOLASE? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BIOLASE and other key companies, straight to your email.

About BIOLASE

BIOLASE (NASDAQ:BIOL), together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

View BIOLASE Profile

More Earnings Resources from MarketBeat

Upcoming Earnings